Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 70

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 70
---
 the Company’s sole related party investment securities as of June 30, 2025 and September 30, 2024. No public market exists for any of the securities of Zander Therapeutics, Inc. The Company owns 7.9% of the total shares of Zander Therapeutics, Inc.

| 55 |

Investments consisted of the following:

SCHEDULE OF INVESTMENT

|                                                 |     |   |              As 
 of June 30,2025 |     |   |                    As 
 of September 30, 2024 |
|:------------------------------------------------|:----|:--|----------------:|:----|:--|----------------------:|
| 470,588                                         
 Common Shares of Zander Therapeutics, Inc.      |     | $ |           6,495 |     | $ |                 6,495 |
| 725,000                                         
 Series M Preferred of Zander Therapeutics, Inc. |     |   |          11,238 |     |   |                11,238 |
| Investments,                                    
 net                                             |     | $ |          17,733 |     | $ |                17,333 |

Common Shares of Zander Therapeutics, Inc.

On June 11, 2018, Regen Biopharma, Inc. was paid a property dividend consisting of 470,588 of the common shares of Zander Therapeutics, Inc.

| Basis |        |     | Fair  
 Value |       |     | Total                   
 Unrealized Gains/(Loss) |         |   |
|:------|-------:|:----|:------|------:|:----|:------------------------|:--------|:--|
| $     | 87,608 |     | $     | 6,495 |     | $                       | (81,112 | ) |

Series M Preferred of Zander Therapeutics, Inc. On November 29, 2018, the Company accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued interest owed to the Company collectively amounting to $13,124.

| Basis |         |     | Fair  
 Value |        |     | Total                   
 Unrealized Gains/(Loss) |          |   |
|:------|--------:|:----|:------|-------:|:----|:------------------------|:---------|:--|
| $     | 134,971 |